Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children: A Single Institution Experience. Issue 1 (19th November 2015)

• Record Type: Journal Article
• Authors: Ferro, Giuseppe; Murthy, Raghav; Williams, Derek; Sebastian, Vinod A.; Forbess, Joseph M.; Guleserian, Kristine J.
• Is Part Of: Artificial organs. Volume 40:Issue 1(2016:Jan.)
• Page Start: 85
• Page End: 89
• Publication Date: 2015-11-19
• Subjects: Pediatric -- Heart failure -- Ventricular assist device -- Cardiac transplantation; Artificial organs -- Periodicals; 617.956
• DOI: 10.1111/aor.12637
• Languages: English
• ISSNs: 0160-564X

Abstract

Abstract: The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant ( N = 7 cardiomyopathy, N = 1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87%) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6–91 days). All transplanted patients are alive and well at a median follow‐up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).